BlackRock Capital Allocation Term Trust (NYSE:BCAT) Sets New 1-Year Low – What’s Next?

Posted by Hayley Millar on Mar 10th, 2025

BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report)’s stock price reached a new 52-week low during trading on Monday . The stock traded as low as $14.96 and last traded at $15.02, with a volume of 620659 shares traded. The stock had previously closed at $15.19.

BlackRock Capital Allocation Term Trust Stock Performance

The business’s 50 day moving average price is $15.47 and its two-hundred day moving average price is $15.94.

BlackRock Capital Allocation Term Trust Increases Dividend

The company also recently announced a monthly dividend, which will be paid on Monday, March 31st. Shareholders of record on Friday, March 14th will be issued a dividend of $0.2872 per share. This is an increase from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10. The ex-dividend date is Friday, March 14th. This represents a $3.45 dividend on an annualized basis and a dividend yield of 22.97%.

Institutional Investors Weigh In On BlackRock Capital Allocation Term Trust

Several hedge funds have recently made changes to their positions in the company. CIBC Private Wealth Group LLC purchased a new position in BlackRock Capital Allocation Term Trust during the fourth quarter valued at $36,000. Anfield Capital Management LLC purchased a new position in BlackRock Capital Allocation Term Trust during the 4th quarter valued at about $56,000. MassMutual Private Wealth & Trust FSB bought a new stake in BlackRock Capital Allocation Term Trust during the fourth quarter worth about $112,000. Comerica Bank grew its holdings in BlackRock Capital Allocation Term Trust by 27.1% in the fourth quarter. Comerica Bank now owns 10,126 shares of the company’s stock worth $153,000 after purchasing an additional 2,157 shares during the period. Finally, Ashton Thomas Securities LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust during the third quarter valued at approximately $156,000. 36.12% of the stock is currently owned by institutional investors.